Non invasive investigation of muscle diseases using 31P magnetic resonance spectroscopy: Potential in clinical applications;Spectrométrie de résonance magnétique du phosphore-31 et maladies musculaires. Avantages, limites et perspectives en clinique

Revue Neurologique

Volumn 158, Issue 5 I, 2002, Pages 527-540

  Bendahan, D ^a   Mattei J P ^a   Kozak Ribbens, G ^a   Cozzone, P J ^a,b  

^a University of Aix Marseille   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUINONE;

BIOCHEMISTRY; CLINICAL EXAMINATION; COMPARATIVE STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROPHYSIOLOGY; ENZYMOLOGY; EXERCISE TOLERANCE; FOLLOW UP; GENE THERAPY; HUMAN; MUSCLE BIOPSY; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE METABOLISM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; ANIMALS; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL MYOPATHIES; MODELS, ANIMAL; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEUROMUSCULAR DISEASES; PHOSPHORUS ISOTOPES; SENSITIVITY AND SPECIFICITY;

EID: 0036113277     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Mapping of metabolites in whole animals by 31-P NMR using surface coil
2. Physical training improves skeletal muscle metabolism in patients with chronic heart failure
3. Bioenergetic heterogeneity of human mitochondrial myopathies: Phosphorus magnetic resonance spectroscopy study
4. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study
5. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy
6. In vivo phosphorus nuclear magnetic resonance (31P-NMR) study of dystrophic hamster muscle
7. Effects of thyroid hormones on skeletal muscle bioenergetics: In vivo phosphorus-31 magnetic resonance spectroscopy study of human and rats
8. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome: A P-31 Nuclear Magnetic Resonance Study
9. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR
10. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy
11. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport
12. Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. An in vivo 31P-NMR spectroscopy study
13. Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31 P-MRS in a patient with mitochondrial cytopathy
14. Heterogeneity of metabolic response to exercise in humans: New criteria of invariance defined by in vivo phosphorus NMR spectroscopy
15. 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle
16. 31-P NMR spectroscopy and ergometer exercice test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies
17. Metabolic and myoelectrical effects of acute hypoxemia during isometric contraction of forearm muscles in humans
18. Combined electromyography-P-31-magnetic resonance spectroscopy study of human muscle fatigue during static contraction
19. Development of a diagnostic score for malignant hyperthermia using 31-P magnetic resonance spectroscopy
20. Characterization of muscular metabolic anomalies in malignant hyperthermia patients: Application to diagnosis
21. 31-P Mrs analysis of muscle energetics changes associated to citrulline-malate in humans
22. Magnetic resonance spectroscopy and histological study of tubular aggregates in a familial myopathy
23. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia
24. Apports de la spectroscopie de résonance magnétique nucléaire du phosphore-31 et du carbone-13 à l'étude du métabolisme myocardique
25. Functional and metabolic early changes in calf muscle occurring during nutritional repletion in malnourished elderly patients
26. An interleaved heteronuclear NMRI-NMRS approach to non-invasive investigation of exercising human skeletal muscle
27. Rat skeletal muscle metabolism in experimental heart failure: Effects of physical training
28. Analyse du muscle squelettique par spectroscopie de RMN du phosphore-31
29. Non invasive, non destructive approaches to cell bioenergetics
30. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: A steady-state analysis of the work/energy cost transfer function
31. Phosphorus magnetic resonance spectroscopy studies of the role of mitochondria in the disease process
32. Effect of rehabilitation after myocardial infarction on muscular metabolism. Contribution of phosphorus 31 NMR spectroscopy
33. Muscle metabolism assessed by phosphorus-31 nuclear magnetic resonance spectroscopy after myocardial infarction in rehabilitated patients: A 1- year follow-up
34. Relationship between increased peak oxygen uptake and modifications in skeletal muscle metabolism following rehabilitation after myocardial infarction
35. P-31 NMR spectroscopy of metabolic changes associated with muscle exercise: Physiopathological applications
36. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy
37. In vivo 31-P magnetic resonance spectroscopy of tender points in patients with primary fibromyalgia syndrome
38. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
39. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis
40. Evidence for abnormal Na+/H+ antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle of patients with essential hypertension
41. Energy status of cells lacking dystrophin: An in vivo/in vitro study of mdx mouse skeletal muscle
42. Glycolysis abnormalities in fibromyalgia
43. Reduced metabolic efficiency of skeletal muscle energetics in hyperthyroid patients evidenced quantitatively by in vivo 31-P MRS
44. Oral creatine supplementation in Duchenne muscular dystrophy: A clinical and 31P magnetic resonance spectroscopy study
45. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6-month therapy study with coenzyme
46. Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice: A 31P NMR study
47. An unusual metabolic myopathy: A malate-aspartate shuttle defect
48. Observation of tissue metabolites using 31-P nuclear magnetic resonance
49. Kinetics of post-exercise phosphate transport in human skeletal muscle: An in vivo 31P-MR spectroscopy study
50. Increased incidence of a resonance in the phosphodiester region of 31-P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients
51. Muscle bioenergetic impairment in hyperthyroid man: A study by 31P NMR spectroscopy
52. Energetic metabolism in hypothyroid skeletal muscle as studied by phosphorus magnetic resonance spectroscopy
53. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy
54. Quantitative interpretation of bioenergetic data from P-31 and H-1 magnetic resonance spectroscopic studies of skeletal muscle - An analytical review
55. Cellular energetics of dystrophic muscle
56. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle
57. The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery
58. Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis
59. Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis
60. In vitro correlation between force and energy metabolism in porcine malignant hyperthermic muscle studied by 31 P NMR
61. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study
62. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31 P-NMR
63. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
64. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study
65. In vivo skeletal muscle mitochondrial function in lebers hereditary optic neuropathy assessed by P-31 magnetic resonance spectroscopy
66. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31 P-MRS
67. P-31 magnetic resonance spectroscopy demonstrates unaltered muscle energy utilization in polymyalgia rheumatica
68. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease
69. Muscle metabolism in older subjects using 31P magnetic resonance spectroscopy
70. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis
71. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy
72. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy
73. A blinded comparison of non invasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia suceptibility
74. Skeletal muscle abnormalities in patients with fibromyalgia
75. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies
76. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia
77. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis
78. Dermatomyositis: Correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease
79. Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31-P magnetic resonance spectroscopy
80. Susceptibility to malignant hyperthermia detected non invasively
81. Impairment of muscular metabolism in chronic respiratory failure. A human 31P MRS study
82. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle
83. Control of bioenergetics: From cells to man by phosphorus nuclear magnetic resonance spectroscopy
84. Assessment of mitochondrial function and control in normal and diseased states
85. Disturbed energy balance in skeletal muscle of patients with untreated primary hypertension
86. Examination of a case of suspected McArdle's syndrome by 31-P nuclear magnetic resonance
87. Phosphorus nuclear magnetic resonance: A non-invasive technique for the study of muscle bioenergetics during exercise
88. Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtRNA?
89. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism
90. Short-term aerobic training response in chronic myopathies
91. Combined aerobic training and dichloroa cetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency
92. Creatine monohydrate increases strength in patients with neuromuscular disease
93. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
94. Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity
95. Bioenergetics of intact human muscle. A 31-P Nuclear Magnetic Resonance Study
96. Ca2+ ATPase deficiency in a patient with an exertional muscle pain syndrome
97. Bioenergetics of skeletal muscle in mitochondrial myopathy
98. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease
99. The effect of propionyl L-camitine on skeletal muscle metabolism in renal failure
100. Interrelationship of oxidative metabolism and local perfusion demonstrated by NMR in human skeletal muscle
101. Phenotypic expression of diabetes secondary to a T 14709 C mutation of mitochondrial DNA. Comparison with the MIDD syndrome (A 3243 G mutation)
102. Extra-pancreatic manifestations in diabetes secondary to mitochondrial DNA point mutation within the tRNA(Leu(UUR)) gene
103. Mitochondrial impairment of human muscle in Friedreich ataxia in vivo
104. Metabolic response to exercise in Malignant Hyperthermia-sensitive patients measured by 31-P magnetic resonance spectroscopy